Why is an ultrasound of the breast recommended before mammography in women under 40 or with dense breast tissue?

Why Ultrasound Before Mammography in Specific Populations

Ultrasound is NOT routinely performed before mammography—mammography remains the primary screening tool for most women—but ultrasound should be the first-line imaging modality for women under 30 years, pregnant or lactating women, and those presenting with palpable breast abnormalities in younger age groups. 1

Primary Imaging Sequence by Age and Clinical Presentation

Women Under 30 Years

• Ultrasound should be performed first (or alone) in women under 30 years presenting with breast symptoms or palpable abnormalities because young women typically have extremely dense breast tissue that significantly limits mammographic sensitivity 2, 1
• Mammographic sensitivity drops to only 23.7% in women with heterogeneously dense breasts, while ultrasound maintains 57-71% sensitivity even in dense tissue 3
• In symptomatic women under 40 years, ultrasound demonstrates superior sensitivity of 95.8% compared to 87.5% for digital mammography 2

Women 30-39 Years

• Either ultrasound or mammography may be performed first at the discretion of the radiologist or referring provider 1
• Ultrasound sensitivity (72.6%) significantly exceeds mammography sensitivity (52.1%) in women younger than 45 years 3
• The critical caveat: ultrasound alone misses ductal carcinoma in situ (DCIS), which mammography detects through microcalcifications 2, 4

Women 40 Years and Older

• Mammography should be performed first, followed by targeted ultrasound for any suspicious findings or palpable abnormalities 1
• This reverses the sequence because mammographic sensitivity improves with age, reaching 82.2% in women with predominantly fatty breasts 3

The Dense Breast Tissue Problem

Why Density Matters

• Approximately 43% of women aged 40-74 years have heterogeneously or extremely dense breasts (BI-RADS categories C and D) 5
• Dense breast tissue both increases breast cancer risk (relative risk 1.23-1.30) AND decreases mammographic sensitivity from 87% in fatty breasts to 63% in extremely dense breasts 5
• Mammography sensitivity decreases as breast density increases, while ultrasound maintains relatively stable performance across density categories 3

Supplemental Screening Context

• For women with dense breasts on screening mammography, ultrasound detects an additional 0.3-7.7 cancers per 1000 examinations, with the ACRIN 6666 trial showing increased detection from 7.6 to 11.8 per 1000 4
• However, this comes at the cost of substantially increased false-positive biopsies, with positive predictive value dropping from 22.6% for mammography alone to 11.2% when ultrasound is added 4
• MRI is superior to ultrasound for supplemental screening in dense breasts (sensitivity 81-100% vs ultrasound's lower performance), but ultrasound serves as an alternative when MRI is contraindicated or unavailable 5, 4

Critical Clinical Algorithm

For Symptomatic/Palpable Findings:

1. Age <30 years: Ultrasound first (or alone) 1
2. Age 30-39 years: Ultrasound OR mammography first, but strongly consider ultrasound given higher sensitivity in this age group 3, 1
3. Age ≥40 years: Mammography first, then targeted ultrasound for any abnormality 1

For Screening in Dense Breasts:

• Continue annual mammography as the primary screening tool 5, 4
• Add supplemental MRI (not ultrasound) as first-line for high-risk women (≥20% lifetime risk) or those with extremely dense breasts 5, 4
• Consider ultrasound only when MRI is contraindicated, unavailable, or unaffordable 5, 4

Common Pitfalls to Avoid

Never Skip Mammography in Women ≥40 Years

• Ultrasound cannot replace mammography because it fails to detect most microcalcifications, which are often the only sign of DCIS 4, 2
• All five false-negative ultrasound cases in one study were DCIS detected by mammography 2

Don't Assume Dense Breasts Alone Justify Supplemental Screening

• Dense breast tissue increases risk modestly (RR 1.23-1.30), but women with dense breasts who develop cancer do not have increased mortality after adjustment for stage and treatment 5
• Risk stratification using validated models is essential before recommending supplemental screening 4

Understand the False-Positive Burden

• Approximately 8-9 negative biopsies occur for every cancer detected when ultrasound is added to mammography 4
• The cumulative probability of false-positive results over 10 years of annual screening in women with extremely dense breasts is 69% 5

Recognize MRI Superiority When Available

• The DENSE trial demonstrated that supplemental MRI reduced interval cancer rates from 5.0 to 2.5 per 1000 screenings in women with extremely dense breasts 6, 4
• MRI cancer detection rate was 16.5 per 1000 screenings compared to 6.2 per 1000 with digital breast tomosynthesis 4